BACKGROUND: Despite evidence suggesting detrimental effects of perioperative hyperoxia, hyperoxygenation remains commonplace in cardiac surgery. Hyperoxygenation may increase oxidative damage and neuronal injury leading to potential differences in postoperative neurocognition. Therefore, this study tested the primary hypothesis that intraoperative normoxia, as compared to hyperoxia, reduces postoperative cognitive dysfunction in older patients having cardiac surgery. METHODS: A randomized double-blind trial was conducted in patients aged 65 yr or older having coronary artery bypass graft surgery with cardiopulmonary bypass. A total of 100 patients were randomized to one of two intraoperative oxygen delivery strategies. Normoxic patients (n = 50) received a minimum fraction of inspired oxygen of 0.35 to maintain a Pao2 above 70 mmHg before and after cardiopulmonary bypass and between 100 and 150 mmHg during cardiopulmonary bypass. Hyperoxic patients (n = 50) received a fraction of inspired oxygen of 1.0 throughout surgery, irrespective of Pao2 levels. The primary outcome was neurocognitive function measured on postoperative day 2 using the Telephonic Montreal Cognitive Assessment. Secondary outcomes included neurocognitive function at 1, 3, and 6 months, as well as postoperative delirium, mortality, and durations of mechanical ventilation, intensive care unit stay, and hospital stay. RESULTS: The median age was 71 yr (interquartile range, 68 to 75), and the median baseline neurocognitive score was 17 (16 to 19). The median intraoperative Pao2 was 309 (285 to 352) mmHg in the hyperoxia group and 153 (133 to 168) mmHg in the normoxia group (P < 0.001). The median Telephonic Montreal Cognitive Assessment score on postoperative day 2 was 18 (16 to 20) in the hyperoxia group and 18 (14 to 20) in the normoxia group (P = 0.42). Neurocognitive function at 1, 3, and 6 months, as well as secondary outcomes, were not statistically different between groups. CONCLUSIONS: In this randomized controlled trial, intraoperative normoxia did not reduce postoperative cognitive dysfunction when compared to intraoperative hyperoxia in older patients having cardiac surgery. Although the optimal intraoperative oxygenation strategy remains uncertain, the results indicate that intraoperative hyperoxia does not worsen postoperative cognition after cardiac surgery.
BACKGROUND: Despite evidence suggesting detrimental effects of perioperative hyperoxia, hyperoxygenation remains commonplace in cardiac surgery. Hyperoxygenation may increase oxidative damage and neuronal injury leading to potential differences in postoperative neurocognition. Therefore, this study tested the primary hypothesis that intraoperative normoxia, as compared to hyperoxia, reduces postoperative cognitive dysfunction in older patients having cardiac surgery. METHODS: A randomized double-blind trial was conducted in patients aged 65 yr or older having coronary artery bypass graft surgery with cardiopulmonary bypass. A total of 100 patients were randomized to one of two intraoperative oxygen delivery strategies. Normoxic patients (n = 50) received a minimum fraction of inspired oxygen of 0.35 to maintain a Pao2 above 70 mmHg before and after cardiopulmonary bypass and between 100 and 150 mmHg during cardiopulmonary bypass. Hyperoxic patients (n = 50) received a fraction of inspired oxygen of 1.0 throughout surgery, irrespective of Pao2 levels. The primary outcome was neurocognitive function measured on postoperative day 2 using the Telephonic Montreal Cognitive Assessment. Secondary outcomes included neurocognitive function at 1, 3, and 6 months, as well as postoperative delirium, mortality, and durations of mechanical ventilation, intensive care unit stay, and hospital stay. RESULTS: The median age was 71 yr (interquartile range, 68 to 75), and the median baseline neurocognitive score was 17 (16 to 19). The median intraoperative Pao2 was 309 (285 to 352) mmHg in the hyperoxia group and 153 (133 to 168) mmHg in the normoxia group (P < 0.001). The median Telephonic Montreal Cognitive Assessment score on postoperative day 2 was 18 (16 to 20) in the hyperoxia group and 18 (14 to 20) in the normoxia group (P = 0.42). Neurocognitive function at 1, 3, and 6 months, as well as secondary outcomes, were not statistically different between groups. CONCLUSIONS: In this randomized controlled trial, intraoperative normoxia did not reduce postoperative cognitive dysfunction when compared to intraoperative hyperoxia in older patients having cardiac surgery. Although the optimal intraoperative oxygenation strategy remains uncertain, the results indicate that intraoperative hyperoxia does not worsen postoperative cognition after cardiac surgery.
Authors: Benedetta Allegranzi; Bassim Zayed; Peter Bischoff; N Zeynep Kubilay; Stijn de Jonge; Fleur de Vries; Stacey M Gomes; Sarah Gans; Elon D Wallert; Xiuwen Wu; Mohamed Abbas; Marja A Boermeester; E Patchen Dellinger; Matthias Egger; Petra Gastmeier; Xavier Guirao; Jianan Ren; Didier Pittet; Joseph S Solomkin Journal: Lancet Infect Dis Date: 2016-11-02 Impact factor: 25.071
Authors: Marcos G Lopez; Christopher G Hughes; Anthony DeMatteo; Jason B O'Neal; J Brennan McNeil; Matthew S Shotwell; Jennifer Morse; Michael R Petracek; Ashish S Shah; Nancy J Brown; Frederic T Billings Journal: Anesthesiology Date: 2020-03 Impact factor: 7.892
Authors: Miles Berger; Niccolò Terrando; S Kendall Smith; Jeffrey N Browndyke; Mark F Newman; Joseph P Mathew Journal: Anesthesiology Date: 2018-10 Impact factor: 7.892
Authors: C Adrian Austin; Thomas O'Gorman; Elizabeth Stern; Douglas Emmett; Til Stürmer; Shannon Carson; Jan Busby-Whitehead Journal: JAMA Surg Date: 2019-04-01 Impact factor: 14.766
Authors: Fred Rincon; Joon Kang; Mitchell Maltenfort; Matthew Vibbert; Jacqueline Urtecho; M Kamran Athar; Jack Jallo; Carissa C Pineda; Diana Tzeng; William McBride; Rodney Bell Journal: Crit Care Med Date: 2014-02 Impact factor: 7.598
Authors: L Evered; B Silbert; D S Knopman; D A Scott; S T DeKosky; L S Rasmussen; E S Oh; G Crosby; M Berger; R G Eckenhoff Journal: Br J Anaesth Date: 2018-06-15 Impact factor: 9.166
Authors: Bob Smit; Yvo M Smulders; Monique C de Waard; Christa Boer; Alexander B A Vonk; Dennis Veerhoek; Suzanne Kamminga; Harm-Jan S de Grooth; Juan J García-Vallejo; Rene J P Musters; Armand R J Girbes; Heleen M Oudemans-van Straaten; Angelique M E Spoelstra-de Man Journal: Crit Care Date: 2016-03-10 Impact factor: 9.097
Authors: Marcos G Lopez; Mias Pretorius; Matthew S Shotwell; Robert Deegan; Susan S Eagle; Jeremy M Bennett; Bantayehu Sileshi; Yafen Liang; Brian J Gelfand; Adam J Kingeter; Kara K Siegrist; Frederick W Lombard; Tiffany M Richburg; Dane A Fornero; Andrew D Shaw; Antonio Hernandez; Frederic T Billings Journal: Trials Date: 2017-06-26 Impact factor: 2.279
Authors: Anthony Calhoun; Ameeka Pannu; Ariel L Mueller; Omar Elmadhoun; Juan D Valencia; Megan L Krajewski; Brian P O'Gara; Anastasia Katsiampoura; Sean T O'Connor; Louis Chu; Erika Monteith; Puja Shankar; Kyle Spear; Shahzad Shaefi Journal: J Cardiothorac Vasc Anesth Date: 2022-01-19 Impact factor: 2.894